nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC2—esophageal cancer	0.496	1	CbGaD
Ofloxacin—ABCC2—Carboplatin—esophageal cancer	0.081	0.281	CbGbCtD
Ofloxacin—ABCC2—Cisplatin—esophageal cancer	0.0692	0.24	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—esophageal cancer	0.0607	0.21	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—esophageal cancer	0.0449	0.156	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—esophageal cancer	0.0329	0.114	CbGbCtD
Ofloxacin—SLC22A4—larynx—esophageal cancer	0.00544	0.28	CbGeAlD
Ofloxacin—SLC22A4—neck—esophageal cancer	0.00144	0.0742	CbGeAlD
Ofloxacin—TOP2A—bronchus—esophageal cancer	0.00121	0.0622	CbGeAlD
Ofloxacin—Sparfloxacin—ABCC2—esophageal cancer	0.000982	0.306	CrCbGaD
Ofloxacin—SLC22A4—bronchus—esophageal cancer	0.000967	0.0497	CbGeAlD
Ofloxacin—SLC22A4—trachea—esophageal cancer	0.000868	0.0447	CbGeAlD
Ofloxacin—Lomefloxacin—ABCC2—esophageal cancer	0.000809	0.252	CrCbGaD
Ofloxacin—TOP2A—lung—esophageal cancer	0.00078	0.0401	CbGeAlD
Ofloxacin—SLC22A4—digestive system—esophageal cancer	0.000747	0.0384	CbGeAlD
Ofloxacin—ABCC1—bronchus—esophageal cancer	0.000727	0.0374	CbGeAlD
Ofloxacin—ABCC1—trachea—esophageal cancer	0.000653	0.0336	CbGeAlD
Ofloxacin—SLC22A5—bronchus—esophageal cancer	0.00064	0.0329	CbGeAlD
Ofloxacin—ABCC2—digestive system—esophageal cancer	0.000638	0.0328	CbGeAlD
Ofloxacin—SLC22A4—lung—esophageal cancer	0.000624	0.0321	CbGeAlD
Ofloxacin—SLC22A5—trachea—esophageal cancer	0.000575	0.0296	CbGeAlD
Ofloxacin—Norfloxacin—CYP2A6—esophageal cancer	0.000554	0.173	CrCbGaD
Ofloxacin—TOP2A—lymph node—esophageal cancer	0.000533	0.0274	CbGeAlD
Ofloxacin—SLC22A5—digestive system—esophageal cancer	0.000494	0.0254	CbGeAlD
Ofloxacin—ABCC1—lung—esophageal cancer	0.000469	0.0241	CbGeAlD
Ofloxacin—CYP1A2—digestive system—esophageal cancer	0.000448	0.023	CbGeAlD
Ofloxacin—SLC22A4—lymph node—esophageal cancer	0.000427	0.0219	CbGeAlD
Ofloxacin—SLC22A5—lung—esophageal cancer	0.000413	0.0212	CbGeAlD
Ofloxacin—CYP1A2—lung—esophageal cancer	0.000374	0.0192	CbGeAlD
Ofloxacin—ABCC2—lymph node—esophageal cancer	0.000364	0.0187	CbGeAlD
Ofloxacin—Sparfloxacin—ABCB1—esophageal cancer	0.000361	0.113	CrCbGaD
Ofloxacin—ABCC1—lymph node—esophageal cancer	0.000321	0.0165	CbGeAlD
Ofloxacin—SLC22A5—lymph node—esophageal cancer	0.000282	0.0145	CbGeAlD
Ofloxacin—Levofloxacin—ABCB1—esophageal cancer	0.000254	0.0793	CrCbGaD
Ofloxacin—Ciprofloxacin—ABCB1—esophageal cancer	0.000246	0.0766	CrCbGaD
Ofloxacin—Arrhythmia—Cisplatin—esophageal cancer	0.000198	0.00139	CcSEcCtD
Ofloxacin—Bronchitis—Capecitabine—esophageal cancer	0.000197	0.00138	CcSEcCtD
Ofloxacin—Alopecia—Cisplatin—esophageal cancer	0.000196	0.00137	CcSEcCtD
Ofloxacin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000196	0.00137	CcSEcCtD
Ofloxacin—Hepatic failure—Methotrexate—esophageal cancer	0.000196	0.00137	CcSEcCtD
Ofloxacin—Pancytopenia—Capecitabine—esophageal cancer	0.000194	0.00136	CcSEcCtD
Ofloxacin—Malnutrition—Cisplatin—esophageal cancer	0.000193	0.00135	CcSEcCtD
Ofloxacin—Erythema—Cisplatin—esophageal cancer	0.000193	0.00135	CcSEcCtD
Ofloxacin—Dysuria—Capecitabine—esophageal cancer	0.000191	0.00134	CcSEcCtD
Ofloxacin—Neutropenia—Capecitabine—esophageal cancer	0.000191	0.00134	CcSEcCtD
Ofloxacin—Renal failure acute—Methotrexate—esophageal cancer	0.000191	0.00134	CcSEcCtD
Ofloxacin—Flatulence—Cisplatin—esophageal cancer	0.000191	0.00133	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00019	0.00133	CcSEcCtD
Ofloxacin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000187	0.00131	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000187	0.00131	CcSEcCtD
Ofloxacin—Visual disturbance—Methotrexate—esophageal cancer	0.000186	0.0013	CcSEcCtD
Ofloxacin—Muscle spasms—Cisplatin—esophageal cancer	0.000186	0.0013	CcSEcCtD
Ofloxacin—Weight decreased—Capecitabine—esophageal cancer	0.000185	0.0013	CcSEcCtD
Ofloxacin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000185	0.00129	CcSEcCtD
Ofloxacin—Pneumonia—Capecitabine—esophageal cancer	0.000183	0.00128	CcSEcCtD
Ofloxacin—Infestation NOS—Capecitabine—esophageal cancer	0.000182	0.00128	CcSEcCtD
Ofloxacin—Infestation—Capecitabine—esophageal cancer	0.000182	0.00128	CcSEcCtD
Ofloxacin—Vision blurred—Cisplatin—esophageal cancer	0.000182	0.00128	CcSEcCtD
Ofloxacin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000182	0.00127	CcSEcCtD
Ofloxacin—Tremor—Cisplatin—esophageal cancer	0.000181	0.00127	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000181	0.00127	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00018	0.00126	CcSEcCtD
Ofloxacin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00018	0.00126	CcSEcCtD
Ofloxacin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000179	0.00126	CcSEcCtD
Ofloxacin—Renal failure—Capecitabine—esophageal cancer	0.000179	0.00125	CcSEcCtD
Ofloxacin—Myocardial infarction—Capecitabine—esophageal cancer	0.000179	0.00125	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000179	0.00125	CcSEcCtD
Ofloxacin—Anaemia—Cisplatin—esophageal cancer	0.000179	0.00125	CcSEcCtD
Ofloxacin—Stomatitis—Capecitabine—esophageal cancer	0.000178	0.00124	CcSEcCtD
Ofloxacin—Jaundice—Capecitabine—esophageal cancer	0.000178	0.00124	CcSEcCtD
Ofloxacin—Conjunctivitis—Capecitabine—esophageal cancer	0.000177	0.00124	CcSEcCtD
Ofloxacin—Osteoarthritis—Methotrexate—esophageal cancer	0.000176	0.00123	CcSEcCtD
Ofloxacin—Malaise—Cisplatin—esophageal cancer	0.000174	0.00122	CcSEcCtD
Ofloxacin—Haematuria—Capecitabine—esophageal cancer	0.000174	0.00122	CcSEcCtD
Ofloxacin—Leukopenia—Cisplatin—esophageal cancer	0.000173	0.00121	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000172	0.00121	CcSEcCtD
Ofloxacin—Epistaxis—Capecitabine—esophageal cancer	0.000172	0.0012	CcSEcCtD
Ofloxacin—Agranulocytosis—Capecitabine—esophageal cancer	0.00017	0.00119	CcSEcCtD
Ofloxacin—Mood swings—Methotrexate—esophageal cancer	0.000167	0.00117	CcSEcCtD
Ofloxacin—Bradycardia—Capecitabine—esophageal cancer	0.000167	0.00117	CcSEcCtD
Ofloxacin—Ataxia—Methotrexate—esophageal cancer	0.000166	0.00116	CcSEcCtD
Ofloxacin—Myalgia—Cisplatin—esophageal cancer	0.000165	0.00115	CcSEcCtD
Ofloxacin—Haemoglobin—Capecitabine—esophageal cancer	0.000165	0.00115	CcSEcCtD
Ofloxacin—Rhinitis—Capecitabine—esophageal cancer	0.000164	0.00115	CcSEcCtD
Ofloxacin—Anxiety—Cisplatin—esophageal cancer	0.000164	0.00115	CcSEcCtD
Ofloxacin—Hepatitis—Capecitabine—esophageal cancer	0.000164	0.00115	CcSEcCtD
Ofloxacin—Haemorrhage—Capecitabine—esophageal cancer	0.000164	0.00115	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000163	0.00114	CcSEcCtD
Ofloxacin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000163	0.00114	CcSEcCtD
Ofloxacin—Discomfort—Cisplatin—esophageal cancer	0.000163	0.00114	CcSEcCtD
Ofloxacin—Pharyngitis—Capecitabine—esophageal cancer	0.000162	0.00114	CcSEcCtD
Ofloxacin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000162	0.00113	CcSEcCtD
Ofloxacin—Oedema peripheral—Capecitabine—esophageal cancer	0.000161	0.00113	CcSEcCtD
Ofloxacin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000161	0.00113	CcSEcCtD
Ofloxacin—Urethral disorder—Capecitabine—esophageal cancer	0.00016	0.00112	CcSEcCtD
Ofloxacin—Breast disorder—Methotrexate—esophageal cancer	0.000159	0.00111	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000159	0.00111	CcSEcCtD
Ofloxacin—Oedema—Cisplatin—esophageal cancer	0.000158	0.0011	CcSEcCtD
Ofloxacin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000158	0.0011	CcSEcCtD
Ofloxacin—Visual impairment—Capecitabine—esophageal cancer	0.000158	0.0011	CcSEcCtD
Ofloxacin—Infection—Cisplatin—esophageal cancer	0.000157	0.0011	CcSEcCtD
Ofloxacin—Erythema multiforme—Capecitabine—esophageal cancer	0.000155	0.00108	CcSEcCtD
Ofloxacin—Nervous system disorder—Cisplatin—esophageal cancer	0.000155	0.00108	CcSEcCtD
Ofloxacin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000154	0.00108	CcSEcCtD
Ofloxacin—Tachycardia—Cisplatin—esophageal cancer	0.000154	0.00108	CcSEcCtD
Ofloxacin—Skin disorder—Cisplatin—esophageal cancer	0.000153	0.00107	CcSEcCtD
Ofloxacin—Eye disorder—Capecitabine—esophageal cancer	0.000153	0.00107	CcSEcCtD
Ofloxacin—Tinnitus—Capecitabine—esophageal cancer	0.000153	0.00107	CcSEcCtD
Ofloxacin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000153	0.00107	CcSEcCtD
Ofloxacin—Asthma—Methotrexate—esophageal cancer	0.000152	0.00107	CcSEcCtD
Ofloxacin—Flushing—Capecitabine—esophageal cancer	0.000152	0.00106	CcSEcCtD
Ofloxacin—Cardiac disorder—Capecitabine—esophageal cancer	0.000152	0.00106	CcSEcCtD
Ofloxacin—Eosinophilia—Methotrexate—esophageal cancer	0.000151	0.00106	CcSEcCtD
Ofloxacin—Anorexia—Cisplatin—esophageal cancer	0.00015	0.00105	CcSEcCtD
Ofloxacin—Pancreatitis—Methotrexate—esophageal cancer	0.000149	0.00104	CcSEcCtD
Ofloxacin—Angiopathy—Capecitabine—esophageal cancer	0.000149	0.00104	CcSEcCtD
Ofloxacin—Immune system disorder—Capecitabine—esophageal cancer	0.000148	0.00103	CcSEcCtD
Ofloxacin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000148	0.00103	CcSEcCtD
Ofloxacin—Hypotension—Cisplatin—esophageal cancer	0.000147	0.00103	CcSEcCtD
Ofloxacin—Chills—Capecitabine—esophageal cancer	0.000147	0.00103	CcSEcCtD
Ofloxacin—Arrhythmia—Capecitabine—esophageal cancer	0.000146	0.00102	CcSEcCtD
Ofloxacin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000146	0.00102	CcSEcCtD
Ofloxacin—Alopecia—Capecitabine—esophageal cancer	0.000145	0.00101	CcSEcCtD
Ofloxacin—Pancytopenia—Methotrexate—esophageal cancer	0.000145	0.00101	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000144	0.00101	CcSEcCtD
Ofloxacin—Mental disorder—Capecitabine—esophageal cancer	0.000143	0.001	CcSEcCtD
Ofloxacin—Malnutrition—Capecitabine—esophageal cancer	0.000143	0.000997	CcSEcCtD
Ofloxacin—Erythema—Capecitabine—esophageal cancer	0.000143	0.000997	CcSEcCtD
Ofloxacin—Dysuria—Methotrexate—esophageal cancer	0.000142	0.000996	CcSEcCtD
Ofloxacin—Neutropenia—Methotrexate—esophageal cancer	0.000142	0.000996	CcSEcCtD
Ofloxacin—Paraesthesia—Cisplatin—esophageal cancer	0.000142	0.000992	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000142	0.00099	CcSEcCtD
Ofloxacin—Dyspnoea—Cisplatin—esophageal cancer	0.000141	0.000985	CcSEcCtD
Ofloxacin—Flatulence—Capecitabine—esophageal cancer	0.00014	0.000983	CcSEcCtD
Ofloxacin—Erectile dysfunction—Methotrexate—esophageal cancer	0.00014	0.000981	CcSEcCtD
Ofloxacin—Dysgeusia—Capecitabine—esophageal cancer	0.00014	0.000977	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000139	0.000973	CcSEcCtD
Ofloxacin—Back pain—Capecitabine—esophageal cancer	0.000138	0.000965	CcSEcCtD
Ofloxacin—Decreased appetite—Cisplatin—esophageal cancer	0.000137	0.00096	CcSEcCtD
Ofloxacin—Muscle spasms—Capecitabine—esophageal cancer	0.000137	0.000959	CcSEcCtD
Ofloxacin—Pneumonia—Methotrexate—esophageal cancer	0.000137	0.000956	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000136	0.000953	CcSEcCtD
Ofloxacin—Infestation—Methotrexate—esophageal cancer	0.000136	0.00095	CcSEcCtD
Ofloxacin—Drowsiness—Methotrexate—esophageal cancer	0.000136	0.00095	CcSEcCtD
Ofloxacin—Infestation NOS—Methotrexate—esophageal cancer	0.000136	0.00095	CcSEcCtD
Ofloxacin—Pain—Cisplatin—esophageal cancer	0.000135	0.000944	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000135	0.000942	CcSEcCtD
Ofloxacin—Vision blurred—Capecitabine—esophageal cancer	0.000134	0.00094	CcSEcCtD
Ofloxacin—Tremor—Capecitabine—esophageal cancer	0.000134	0.000935	CcSEcCtD
Ofloxacin—Renal failure—Methotrexate—esophageal cancer	0.000133	0.000934	CcSEcCtD
Ofloxacin—Stomatitis—Methotrexate—esophageal cancer	0.000132	0.000926	CcSEcCtD
Ofloxacin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000132	0.000925	CcSEcCtD
Ofloxacin—Conjunctivitis—Methotrexate—esophageal cancer	0.000132	0.000924	CcSEcCtD
Ofloxacin—Anaemia—Capecitabine—esophageal cancer	0.000132	0.000922	CcSEcCtD
Ofloxacin—Feeling abnormal—Cisplatin—esophageal cancer	0.00013	0.00091	CcSEcCtD
Ofloxacin—Haematuria—Methotrexate—esophageal cancer	0.000129	0.000906	CcSEcCtD
Ofloxacin—Malaise—Capecitabine—esophageal cancer	0.000129	0.000899	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000128	0.000899	CcSEcCtD
Ofloxacin—Epistaxis—Methotrexate—esophageal cancer	0.000128	0.000896	CcSEcCtD
Ofloxacin—Vertigo—Capecitabine—esophageal cancer	0.000128	0.000896	CcSEcCtD
Ofloxacin—Syncope—Capecitabine—esophageal cancer	0.000128	0.000894	CcSEcCtD
Ofloxacin—Leukopenia—Capecitabine—esophageal cancer	0.000128	0.000893	CcSEcCtD
Ofloxacin—Agranulocytosis—Methotrexate—esophageal cancer	0.000127	0.000887	CcSEcCtD
Ofloxacin—Palpitations—Capecitabine—esophageal cancer	0.000126	0.000881	CcSEcCtD
Ofloxacin—Loss of consciousness—Capecitabine—esophageal cancer	0.000125	0.000877	CcSEcCtD
Ofloxacin—Body temperature increased—Cisplatin—esophageal cancer	0.000125	0.000873	CcSEcCtD
Ofloxacin—Cough—Capecitabine—esophageal cancer	0.000124	0.00087	CcSEcCtD
Ofloxacin—Hypertension—Capecitabine—esophageal cancer	0.000123	0.000861	CcSEcCtD
Ofloxacin—Haemoglobin—Methotrexate—esophageal cancer	0.000122	0.000857	CcSEcCtD
Ofloxacin—Haemorrhage—Methotrexate—esophageal cancer	0.000122	0.000853	CcSEcCtD
Ofloxacin—Hepatitis—Methotrexate—esophageal cancer	0.000122	0.000853	CcSEcCtD
Ofloxacin—Chest pain—Capecitabine—esophageal cancer	0.000121	0.000849	CcSEcCtD
Ofloxacin—Arthralgia—Capecitabine—esophageal cancer	0.000121	0.000849	CcSEcCtD
Ofloxacin—Myalgia—Capecitabine—esophageal cancer	0.000121	0.000849	CcSEcCtD
Ofloxacin—Pharyngitis—Methotrexate—esophageal cancer	0.000121	0.000847	CcSEcCtD
Ofloxacin—Anxiety—Capecitabine—esophageal cancer	0.000121	0.000846	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00012	0.000843	CcSEcCtD
Ofloxacin—Urinary tract disorder—Methotrexate—esophageal cancer	0.00012	0.000842	CcSEcCtD
Ofloxacin—Discomfort—Capecitabine—esophageal cancer	0.00012	0.000839	CcSEcCtD
Ofloxacin—Urethral disorder—Methotrexate—esophageal cancer	0.000119	0.000836	CcSEcCtD
Ofloxacin—Dry mouth—Capecitabine—esophageal cancer	0.000119	0.00083	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—esophageal cancer	0.000117	0.000822	CcSEcCtD
Ofloxacin—Confusional state—Capecitabine—esophageal cancer	0.000117	0.000821	CcSEcCtD
Ofloxacin—Oedema—Capecitabine—esophageal cancer	0.000116	0.000814	CcSEcCtD
Ofloxacin—Hypersensitivity—Cisplatin—esophageal cancer	0.000116	0.000814	CcSEcCtD
Ofloxacin—Infection—Capecitabine—esophageal cancer	0.000116	0.000809	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—esophageal cancer	0.000115	0.000806	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000115	0.00232	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000115	0.00232	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000115	0.00232	CbGpPWpGaD
Ofloxacin—Shock—Capecitabine—esophageal cancer	0.000114	0.000801	CcSEcCtD
Ofloxacin—Nervous system disorder—Capecitabine—esophageal cancer	0.000114	0.000798	CcSEcCtD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000114	0.0023	CbGpPWpGaD
Ofloxacin—Eye disorder—Methotrexate—esophageal cancer	0.000114	0.000797	CcSEcCtD
Ofloxacin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000114	0.000797	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—esophageal cancer	0.000114	0.000795	CcSEcCtD
Ofloxacin—Tachycardia—Capecitabine—esophageal cancer	0.000114	0.000794	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000113	0.00229	CbGpPWpGaD
Ofloxacin—Asthenia—Cisplatin—esophageal cancer	0.000113	0.000792	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—esophageal cancer	0.000113	0.000792	CcSEcCtD
Ofloxacin—Skin disorder—Capecitabine—esophageal cancer	0.000113	0.000791	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000113	0.00227	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000112	0.000787	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—TGFBR2—esophageal cancer	0.000112	0.00225	CbGpPWpGaD
Ofloxacin—Anorexia—Capecitabine—esophageal cancer	0.000111	0.000776	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—esophageal cancer	0.000111	0.000774	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—esophageal cancer	0.00011	0.00077	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—HMOX1—esophageal cancer	0.00011	0.00222	CbGpPWpGaD
Ofloxacin—Mediastinal disorder—Methotrexate—esophageal cancer	0.00011	0.000769	CcSEcCtD
Ofloxacin—Chills—Methotrexate—esophageal cancer	0.000109	0.000765	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000109	0.0022	CbGpPWpGaD
Ofloxacin—Hypotension—Capecitabine—esophageal cancer	0.000109	0.000761	CcSEcCtD
Ofloxacin—Diarrhoea—Cisplatin—esophageal cancer	0.000108	0.000756	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—esophageal cancer	0.000108	0.000754	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000107	0.00216	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.000107	0.00216	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000107	0.00215	CbGpPWpGaD
Ofloxacin—Mental disorder—Methotrexate—esophageal cancer	0.000107	0.000747	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000107	0.00215	CbGpPWpGaD
Ofloxacin—Erythema—Methotrexate—esophageal cancer	0.000106	0.000743	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—esophageal cancer	0.000106	0.000743	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000106	0.000742	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000105	0.00212	CbGpPWpGaD
Ofloxacin—Insomnia—Capecitabine—esophageal cancer	0.000105	0.000736	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000105	0.00211	CbGpPWpGaD
Ofloxacin—Paraesthesia—Capecitabine—esophageal cancer	0.000104	0.000731	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—esophageal cancer	0.000104	0.000727	CcSEcCtD
Ofloxacin—Dyspnoea—Capecitabine—esophageal cancer	0.000104	0.000726	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000103	0.00208	CbGpPWpGaD
Ofloxacin—Back pain—Methotrexate—esophageal cancer	0.000103	0.000718	CcSEcCtD
Ofloxacin—Dyspepsia—Capecitabine—esophageal cancer	0.000102	0.000717	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000102	0.00206	CbGpPWpGaD
Ofloxacin—Decreased appetite—Capecitabine—esophageal cancer	0.000101	0.000708	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0001	0.000703	CcSEcCtD
Ofloxacin—Vomiting—Cisplatin—esophageal cancer	0.0001	0.000702	CcSEcCtD
Ofloxacin—Fatigue—Capecitabine—esophageal cancer	0.0001	0.000702	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.0001	0.00202	CbGpPWpGaD
Ofloxacin—Vision blurred—Methotrexate—esophageal cancer	0.0001	0.0007	CcSEcCtD
Ofloxacin—Rash—Cisplatin—esophageal cancer	9.95e-05	0.000696	CcSEcCtD
Ofloxacin—Pain—Capecitabine—esophageal cancer	9.95e-05	0.000696	CcSEcCtD
Ofloxacin—Constipation—Capecitabine—esophageal cancer	9.95e-05	0.000696	CcSEcCtD
Ofloxacin—Dermatitis—Cisplatin—esophageal cancer	9.94e-05	0.000696	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	9.86e-05	0.00199	CbGpPWpGaD
Ofloxacin—Ill-defined disorder—Methotrexate—esophageal cancer	9.84e-05	0.000689	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—esophageal cancer	9.81e-05	0.000686	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	9.8e-05	0.00198	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.7e-05	0.00196	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	9.68e-05	0.00195	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.59e-05	0.00193	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Capecitabine—esophageal cancer	9.58e-05	0.000671	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—esophageal cancer	9.57e-05	0.00067	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	9.55e-05	0.00193	CbGpPWpGaD
Ofloxacin—Vertigo—Methotrexate—esophageal cancer	9.53e-05	0.000667	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Capecitabine—esophageal cancer	9.51e-05	0.000666	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—esophageal cancer	9.5e-05	0.000665	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.49e-05	0.00191	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	9.45e-05	0.0019	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	9.44e-05	0.0019	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	9.4e-05	0.00189	CbGpPWpGaD
Ofloxacin—Nausea—Cisplatin—esophageal cancer	9.37e-05	0.000656	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	9.35e-05	0.00188	CbGpPWpGaD
Ofloxacin—Cough—Methotrexate—esophageal cancer	9.26e-05	0.000648	CcSEcCtD
Ofloxacin—Urticaria—Capecitabine—esophageal cancer	9.24e-05	0.000647	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	9.22e-05	0.00186	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.2e-05	0.00185	CbGpPWpGaD
Ofloxacin—Abdominal pain—Capecitabine—esophageal cancer	9.19e-05	0.000644	CcSEcCtD
Ofloxacin—Body temperature increased—Capecitabine—esophageal cancer	9.19e-05	0.000644	CcSEcCtD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	9.1e-05	0.00183	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.09e-05	0.00183	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	9.06e-05	0.00183	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.06e-05	0.00183	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	9.05e-05	0.00182	CbGpPWpGaD
Ofloxacin—Myalgia—Methotrexate—esophageal cancer	9.03e-05	0.000632	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—esophageal cancer	9.03e-05	0.000632	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—esophageal cancer	9.03e-05	0.000632	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—ADH7—esophageal cancer	9.02e-05	0.00182	CbGpPWpGaD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	8.97e-05	0.000628	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—esophageal cancer	8.92e-05	0.000625	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.77e-05	0.00177	CbGpPWpGaD
Ofloxacin—Confusional state—Methotrexate—esophageal cancer	8.73e-05	0.000611	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.72e-05	0.00176	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	8.69e-05	0.00175	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.68e-05	0.00175	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.68e-05	0.00175	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.67e-05	0.00175	CbGpPWpGaD
Ofloxacin—Anaphylactic shock—Methotrexate—esophageal cancer	8.66e-05	0.000606	CcSEcCtD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	8.64e-05	0.00174	CbGpPWpGaD
Ofloxacin—Infection—Methotrexate—esophageal cancer	8.6e-05	0.000602	CcSEcCtD
Ofloxacin—Hypersensitivity—Capecitabine—esophageal cancer	8.57e-05	0.0006	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—esophageal cancer	8.49e-05	0.000594	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—esophageal cancer	8.48e-05	0.000593	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	8.44e-05	0.0017	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.41e-05	0.0017	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.41e-05	0.0017	CbGpPWpGaD
Ofloxacin—Skin disorder—Methotrexate—esophageal cancer	8.41e-05	0.000589	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—esophageal cancer	8.37e-05	0.000586	CcSEcCtD
Ofloxacin—Asthenia—Capecitabine—esophageal cancer	8.34e-05	0.000584	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.31e-05	0.00168	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.31e-05	0.00168	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	8.29e-05	0.00167	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	8.29e-05	0.00167	CbGpPWpGaD
Ofloxacin—Anorexia—Methotrexate—esophageal cancer	8.25e-05	0.000578	CcSEcCtD
Ofloxacin—Pruritus—Capecitabine—esophageal cancer	8.23e-05	0.000576	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	8.17e-05	0.00165	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	8.13e-05	0.00164	CbGpPWpGaD
Ofloxacin—Hypotension—Methotrexate—esophageal cancer	8.09e-05	0.000566	CcSEcCtD
Ofloxacin—Diarrhoea—Capecitabine—esophageal cancer	7.96e-05	0.000557	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	7.95e-05	0.0016	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	7.94e-05	0.0016	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.91e-05	0.00159	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	7.91e-05	0.00159	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	7.89e-05	0.000552	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—esophageal cancer	7.83e-05	0.000548	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—esophageal cancer	7.77e-05	0.000544	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—esophageal cancer	7.72e-05	0.00054	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—esophageal cancer	7.7e-05	0.000539	CcSEcCtD
Ofloxacin—Dizziness—Capecitabine—esophageal cancer	7.69e-05	0.000538	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	7.68e-05	0.00155	CbGpPWpGaD
Ofloxacin—Dyspepsia—Methotrexate—esophageal cancer	7.62e-05	0.000533	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	7.54e-05	0.00152	CbGpPWpGaD
Ofloxacin—Decreased appetite—Methotrexate—esophageal cancer	7.53e-05	0.000527	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—esophageal cancer	7.48e-05	0.000523	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	7.47e-05	0.00151	CbGpPWpGaD
Ofloxacin—Fatigue—Methotrexate—esophageal cancer	7.46e-05	0.000522	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	7.43e-05	0.0015	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PSME2—esophageal cancer	7.41e-05	0.00149	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PSME1—esophageal cancer	7.41e-05	0.00149	CbGpPWpGaD
Ofloxacin—Pain—Methotrexate—esophageal cancer	7.4e-05	0.000518	CcSEcCtD
Ofloxacin—Vomiting—Capecitabine—esophageal cancer	7.4e-05	0.000518	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	7.35e-05	0.00148	CbGpPWpGaD
Ofloxacin—Rash—Capecitabine—esophageal cancer	7.33e-05	0.000513	CcSEcCtD
Ofloxacin—Dermatitis—Capecitabine—esophageal cancer	7.33e-05	0.000513	CcSEcCtD
Ofloxacin—Headache—Capecitabine—esophageal cancer	7.29e-05	0.00051	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	7.25e-05	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.24e-05	0.00146	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Methotrexate—esophageal cancer	7.14e-05	0.000499	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—esophageal cancer	7.08e-05	0.000496	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	7.01e-05	0.00141	CbGpPWpGaD
Ofloxacin—Nausea—Capecitabine—esophageal cancer	6.91e-05	0.000484	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—esophageal cancer	6.88e-05	0.000481	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—esophageal cancer	6.84e-05	0.000479	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—esophageal cancer	6.84e-05	0.000479	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	6.83e-05	0.00138	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.81e-05	0.00137	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BUB1B—esophageal cancer	6.74e-05	0.00136	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	6.74e-05	0.00136	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC52A3—esophageal cancer	6.71e-05	0.00135	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.66e-05	0.00134	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	6.65e-05	0.00134	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.58e-05	0.00133	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CHEK2—esophageal cancer	6.42e-05	0.00129	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.41e-05	0.00129	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KMT2D—esophageal cancer	6.4e-05	0.00129	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Methotrexate—esophageal cancer	6.38e-05	0.000446	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	6.37e-05	0.00128	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.32e-05	0.00127	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.3e-05	0.00127	CbGpPWpGaD
Ofloxacin—Asthenia—Methotrexate—esophageal cancer	6.21e-05	0.000435	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.15e-05	0.00124	CbGpPWpGaD
Ofloxacin—Pruritus—Methotrexate—esophageal cancer	6.13e-05	0.000429	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.01e-05	0.00121	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.97e-05	0.0012	CbGpPWpGaD
Ofloxacin—Diarrhoea—Methotrexate—esophageal cancer	5.92e-05	0.000415	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.82e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.78e-05	0.00117	CbGpPWpGaD
Ofloxacin—Dizziness—Methotrexate—esophageal cancer	5.73e-05	0.000401	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.72e-05	0.00115	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BLVRB—esophageal cancer	5.62e-05	0.00113	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC52A3—esophageal cancer	5.62e-05	0.00113	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	5.57e-05	0.00112	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.54e-05	0.00112	CbGpPWpGaD
Ofloxacin—Vomiting—Methotrexate—esophageal cancer	5.51e-05	0.000385	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	5.47e-05	0.0011	CbGpPWpGaD
Ofloxacin—Rash—Methotrexate—esophageal cancer	5.46e-05	0.000382	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—esophageal cancer	5.45e-05	0.000382	CcSEcCtD
Ofloxacin—Headache—Methotrexate—esophageal cancer	5.42e-05	0.00038	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	5.32e-05	0.00107	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	5.3e-05	0.00107	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	5.24e-05	0.00106	CbGpPWpGaD
Ofloxacin—Nausea—Methotrexate—esophageal cancer	5.14e-05	0.00036	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	5.11e-05	0.00103	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.02e-05	0.00101	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	4.97e-05	0.001	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FKBP1A—esophageal cancer	4.96e-05	0.001	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—WIF1—esophageal cancer	4.85e-05	0.000977	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DOCK2—esophageal cancer	4.85e-05	0.000977	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.82e-05	0.000973	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.82e-05	0.000972	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	4.78e-05	0.000963	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA1—esophageal cancer	4.78e-05	0.000963	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC10A2—esophageal cancer	4.78e-05	0.000963	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.72e-05	0.000951	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.63e-05	0.000933	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	4.55e-05	0.000916	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	4.55e-05	0.000916	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CSNK1A1—esophageal cancer	4.47e-05	0.000902	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA2—esophageal cancer	4.37e-05	0.000881	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.27e-05	0.000861	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	4.22e-05	0.000851	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	4.16e-05	0.000839	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.11e-05	0.000829	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.1e-05	0.000826	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	4.07e-05	0.000821	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLCE1—esophageal cancer	4.06e-05	0.000819	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADH7—esophageal cancer	4.06e-05	0.000819	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.01e-05	0.000809	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	3.97e-05	0.0008	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.96e-05	0.000799	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	3.96e-05	0.000799	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	3.92e-05	0.00079	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	3.92e-05	0.000789	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	3.87e-05	0.000781	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	3.87e-05	0.000781	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	3.8e-05	0.000767	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ELMO1—esophageal cancer	3.76e-05	0.000758	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GSTO1—esophageal cancer	3.67e-05	0.000741	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TPI1—esophageal cancer	3.67e-05	0.000741	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.64e-05	0.000733	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADH1B—esophageal cancer	3.56e-05	0.000718	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.52e-05	0.00071	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ALDOB—esophageal cancer	3.52e-05	0.00071	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RB1—esophageal cancer	3.51e-05	0.000707	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.49e-05	0.000704	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.48e-05	0.000702	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	3.45e-05	0.000695	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMP—esophageal cancer	3.4e-05	0.000686	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GAPDH—esophageal cancer	3.39e-05	0.000684	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIST1H2BM—esophageal cancer	3.39e-05	0.000684	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.38e-05	0.000682	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.34e-05	0.000674	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP26A1—esophageal cancer	3.31e-05	0.000667	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX15—esophageal cancer	3.23e-05	0.00065	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.09e-05	0.000623	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	3.08e-05	0.000621	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTO1—esophageal cancer	3.08e-05	0.00062	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TPI1—esophageal cancer	3.08e-05	0.00062	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—XIAP—esophageal cancer	3e-05	0.000604	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALDOB—esophageal cancer	2.95e-05	0.000595	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	2.91e-05	0.000587	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GAPDH—esophageal cancer	2.84e-05	0.000573	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	2.82e-05	0.000568	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CRABP1—esophageal cancer	2.81e-05	0.000567	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—B2M—esophageal cancer	2.78e-05	0.000561	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.75e-05	0.000555	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	2.68e-05	0.00054	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GNG7—esophageal cancer	2.68e-05	0.00054	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ENO1—esophageal cancer	2.67e-05	0.000538	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSME1—esophageal cancer	2.63e-05	0.00053	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSME2—esophageal cancer	2.63e-05	0.00053	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—esophageal cancer	2.6e-05	0.000525	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALR—esophageal cancer	2.52e-05	0.000509	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	2.52e-05	0.000508	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALDH2—esophageal cancer	2.51e-05	0.000506	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FBXW7—esophageal cancer	2.44e-05	0.000492	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.4e-05	0.000484	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—EP300—esophageal cancer	2.4e-05	0.000483	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTT1—esophageal cancer	2.39e-05	0.000481	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2A6—esophageal cancer	2.36e-05	0.000475	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.35e-05	0.000474	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	2.34e-05	0.000471	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.33e-05	0.00047	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.26e-05	0.000456	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ENO1—esophageal cancer	2.24e-05	0.000451	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS1—esophageal cancer	2.24e-05	0.000451	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.23e-05	0.00045	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSME1—esophageal cancer	2.2e-05	0.000444	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSME2—esophageal cancer	2.2e-05	0.000444	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.13e-05	0.00043	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.13e-05	0.00043	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—esophageal cancer	2.09e-05	0.000421	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFBR2—esophageal cancer	1.97e-05	0.000398	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.92e-05	0.000388	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.91e-05	0.000384	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1B1—esophageal cancer	1.9e-05	0.000383	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMAD4—esophageal cancer	1.87e-05	0.000377	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.81e-05	0.000366	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA1—esophageal cancer	1.81e-05	0.000366	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP19A1—esophageal cancer	1.79e-05	0.00036	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—esophageal cancer	1.72e-05	0.000346	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA2—esophageal cancer	1.66e-05	0.000334	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMOX1—esophageal cancer	1.63e-05	0.000329	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.62e-05	0.000327	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.6e-05	0.000323	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—esophageal cancer	1.57e-05	0.000316	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADH7—esophageal cancer	1.54e-05	0.000311	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.54e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—esophageal cancer	1.53e-05	0.000308	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.52e-05	0.000307	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS2—esophageal cancer	1.39e-05	0.000281	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOTCH1—esophageal cancer	1.38e-05	0.000278	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.35e-05	0.000273	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMP—esophageal cancer	1.29e-05	0.000261	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.26e-05	0.000253	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CREBBP—esophageal cancer	1.25e-05	0.000252	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.23e-05	0.000247	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.18e-05	0.000239	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.17e-05	0.000236	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TPI1—esophageal cancer	1.17e-05	0.000236	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.12e-05	0.000226	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS3—esophageal cancer	1.12e-05	0.000226	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.08e-05	0.000217	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.07e-05	0.000215	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CREBBP—esophageal cancer	1.05e-05	0.000211	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB2—esophageal cancer	1.05e-05	0.000211	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—esophageal cancer	1.02e-05	0.000206	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GNG7—esophageal cancer	1.02e-05	0.000205	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.53e-06	0.000192	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NOS3—esophageal cancer	9.37e-06	0.000189	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.06e-06	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	8.96e-06	0.000181	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1A—esophageal cancer	8.94e-06	0.00018	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.92e-06	0.00018	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—esophageal cancer	8.57e-06	0.000173	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EP300—esophageal cancer	8.51e-06	0.000172	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO1—esophageal cancer	8.49e-06	0.000171	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.49e-06	0.000171	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSME2—esophageal cancer	8.37e-06	0.000169	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSME1—esophageal cancer	8.37e-06	0.000169	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—esophageal cancer	7.42e-06	0.000149	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.31e-06	0.000147	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—esophageal cancer	7.25e-06	0.000146	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.22e-06	0.000146	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—EP300—esophageal cancer	7.13e-06	0.000144	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.79e-06	0.000137	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—esophageal cancer	6.29e-06	0.000127	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.2e-06	0.000125	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.08e-06	0.000123	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.95e-06	0.00012	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—esophageal cancer	5.27e-06	0.000106	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.5e-06	9.06e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.97e-06	8.01e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NOS3—esophageal cancer	3.56e-06	7.17e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.25e-06	6.56e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—EP300—esophageal cancer	2.71e-06	5.46e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2e-06	4.04e-05	CbGpPWpGaD
